Jingao Li
7PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 11, 2025
Anti-LAG-3 Antibody LBL-007 plus Tislelizumab and Chemotherapy as First-Line Therapy for Advanced Nasopharyngeal Carcinoma: A Multicenter Phase 2 Trial.Dongchen Sun, Gang Chen, Yu Chen
|Jun 23, 2025
Prognostic Significance of Circulating Immune Subset Counts in Nasopharyngeal Carcinoma.Honghui Xie, Lin Zhang, Lizhi Chen
|Mar 29, 2024
Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer: A Systematic Review and Meta-analysis.Baomin Zheng, Meilin He, Yaqian Han
|Nov 29, 2023
A Novel Prognostic Model Predicts Outcomes in Non-Metastatic Nasopharyngeal Carcinoma Based on Inflammation, Nutrition, and Coagulation Signature.Li-Zhi Chen, Han-Shu Li, Gao-Wei Han
|Mar 30, 2023
Impaired geriatric 8 score is associated with worse survival after radical intensity modulated radiation therapy in elderly patients with nasopharyngeal carcinoma.Zhaohui Liao, Li Zhao, Xiaopeng Xiong
|Jun 16, 2022
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.Yuan Zhang, Lei Chen, Guo-Qing Hu
Pageof 2
